Skip to content
healthcare.dev

HYRIMOZ

NDC 83457-107, adalimumab-adaz, injection, solution, from Cordavis Limited.

Product NDC
83457-107
Status
Listed
Labeler
Cordavis Limited
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761071
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83457-107 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ADALIMUMAB80 mg/.8mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Package NDCNDC-11Package
83457-107-01834570107012 SYRINGE in 1 CARTON (83457-107-01) / .8 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3e303a4a-980b-4f2a-9d03-786928758637

Use it

Look up 83457-107 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83457-107 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83457-107. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.